INMUNE BIO INC. (INMB) Operating cash flow 2017–2025
INMUNE BIO INC. (INMB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$22.6MFY2025 · since FY2017: -$761,834 → -$22.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.6M | +32.3% |
| FY2024 | -$33.4M | -178.5% |
| FY2023 | -$12.0M | +47.2% |
| FY2022 | -$22.7M | +20.4% |
| FY2021 | -$28.5M | -218.7% |
| FY2020 | -$8.9M | -66.1% |
| FY2019 | -$5.4M | -161.5% |
| FY2018 | -$2.1M | -170.3% |
| FY2017 | -$761,834 | — |
Source: SEC XBRL filings · For reference only · Not investment advice